CIDEB targeting small interfering RNA (RONA Therapeutics)

N/A

Report date: 2024/09/13 10:06:37
NME

Base Information

Drug NameCIDEB targeting small interfering RNA (RONA Therapeutics)
Drug Alias NamesiRNA therapeutics targeting CIDEB for metabolic dysfunction-associated steatohepatitis (RONA Therapeutics)
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionApoptosis regulatory proteins modulatorsRNA interference
TargetsApoptosis regulatory proteins
Therapy Area/IndicationsMetabolic Dysfunction-Associated Steatotic Liver Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesDarui Biomedical Technology (Shanghai) Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesDarui Biomedical Technology (Shanghai) Co Ltd
Inactive CompaniesN/A
Active IndicationsMetabolic Dysfunction-Associated Steatotic Liver Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A